 |
October 1st, 2007: Solubilization at the forefront of Cancer research - an article describing the formulation and in vivo activity evaluation of a novel compound utilizing Neowater® solubilization enhancer
| Demonstration of Neowater®'s solubilization service capabilities in a recently published article: In an experiment done in Israel in the lab of Dr. Fortune Kohen at the Weizmann Institute of Science, Derivatives of Carboxyalkyl Isoflavones linked to N-t-Boc-hexylenediamine were tested for their anti-proliferative activity in-vivo and in-vitro. One of these compounds was solubilized by Neowater® Solubilization service and didn't show any advert toxicity apart from it's expected anti-proliferative activity. |  |
Drug development | Enzyme Stabilization | Protein Stabilization | Pharma – Pharmaceutical companies
 |
| About Us | Core technology | Pharma | BioPharma | Diagnostics | News | Contact us | Site map | Resources | Drug Delivery Articles |
 |
|
All Rights Reserved to Do-Coop Technologies Ltd - A
drug development and
Drug formulation Company that developed an Innovatinve
drug delivery system called - Neowater®.
Docoop drug delivery system covers Hydrophobic compounds, solubilization service, Small molecule solubilization, Antibody stabilization, Protein stabilization, Enzyme stabilization, Stem cell viability, Stem cell growth, Cell line viability, Cell line growth, Stem cells media and Cell line cryopreservation. With Docoop the formulation of drugs is a fast, high quality and time saving process. Learn here about Solubilization, Cryopreservation and Drug screening. | 
Encountered with a broken link or other Website malfunction? Please contact the Site Administrator This site is best viewed on Internet explorer version 5.5 or higher |